Novo Nordisk A/S (NVO) by event type
NVO moves most on coverage initiations — a median of +0.19% at 30 minutes across 31 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the NVO overview →
How NVO reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 1,279 of 2,717 | 54 | +0.03% | 52% | +0.20% |
| Analyst downgrades 1,767 of 2,603 | 63 | -0.13% | 46% | +0.23% |
| Coverage initiations 742 of 2,283 | 31 | +0.19% | 74% | +0.22% |
| Rating reiterations 1,137 of 3,522 | 69 | +0.06% | 55% | -0.06% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how NVO usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · NVO overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Endo International plc - Ordinary Shares (ENDP) | 2,000+ | 0.00% | 49% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2,000+ | +0.11% | 56% |
| CELGENE (CELG) | 1,880 | +0.03% | 52% |
| Capricor Therapeutics, Inc. (CAPR) | 1,806 | -0.20% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.